Yecyec, Jesus N.

HRN: 10-15-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/29/2025
09/05/2025
IV
4.5gm
Q8h
CUTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines